ro vs hims glp-1 vs. Weight Loss 2025: How Do They Compare? GLP-1s powering Hims & Hers
Description
Glycemic Control: advantage goes to Orforglipron
Traditional Therapeutic Targets Related to Obesity GDF8 GDF8 (Growth Differentiation Factor 8), commonly known as Myostatin (MSTN), is a protein predominantly expressed by skeletal muscle cells and is a member of the TGF- (Transforming Growth Factor-) superfamily
Nearly 3 billion people around the world were considered overweight or obese in 2022, including one in eight adults who were classified as obese (WHO, 2024)
However, this coverage comes at a high cost, with GLP-1s accounting for 8.9% of their total health claims expenses
In August, the U.S
